March 17, 2026. 14 cannabis news items, curated from live RSS feeds. Sorted by relevance score.
Texas hemp businesses brace for stricter THC rules starting March 31 | myfoxzone.com
# Article Summary Texas will enforce stricter THC limits (0.3% maximum) for hemp-derived products starting March 31, affecting state business operations and product compliance standards.
Read more →Texas hemp business owners fear impact of stricter THC regulations taking effect March 31
Texas hemp businesses face potential closures as new regulations effective March 31 will ban products exceeding 0.3% THC, now including THCA, affecting the legal cannabis market.
Read more →States move to tighten hemp THC rules ahead of federal ban – MJBizDaily
# Clinical Relevance Summary States are implementing stricter regulations on hemp-derived THC products as federal restrictions tighten, with implications for cannabinoid product availability and standardization.
Read more →The $300 a week medicine Daniel feels better without – SMH
# Article Summary A University of Sydney study examines medicinal cannabis efficacy, referencing Therapeutic Goods Administration submissions regarding its therapeutic use and regulatory evaluation.
Read more →Colombian Researcher Creates Cannabis-based Therapies for Sick Cats and Dogs
# Article Summary A Colombian researcher develops cannabis-derived therapeutic treatments for domestic animals, targeting pain, appetite, and mood regulation through the endocannabinoid system.
Read more →Breakout Alert: ARTL – Small Cap Exclusive
Artelo Biosciences develops clinical-stage therapeutics targeting the endocannabinoid system for potential therapeutic applications.
Read more →Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies …
# Clinical Summary This article examines the GPR55 receptor and cannabinoid signaling pathways as potential therapeutic targets for treating metabolic-associated fatty liver disease and steatohepatitis.
Read more →State officials urge safe cannabis storage during National Poison Prevention Week
State cannabis officials promote safe storage practices during National Poison Prevention Week to reduce accidental poisoning risk, particularly among children.
Read more →Do you use cannabis for mental health symptoms? – YouTube
# Summary A study findings suggest cannabis use for mental health symptom management lacks efficacy, questioning its therapeutic value for psychiatric conditions.
Read more →New study suggests marijuana won’t ease anxiety, common mental health problems
# Article Summary Recent research indicates marijuana is ineffective for treating anxiety and other mental health conditions including anorexia nervosa and bipolar disorder.
Read more →New study suggests marijuana won’t ease anxiety, common mental health problems – KKTV
A recent study challenges the therapeutic use of marijuana for anxiety and depression, suggesting it may not provide the mental health benefits commonly attributed to it.
Read more →Medical cannabis not effective as a mental health treatment, finds meta analysis
A meta-analysis questions medical cannabis’s effectiveness for mental health treatment, though industry groups suggest alternative interpretations of the evidence exist.
Read more →Scientists say marijuana doesn’t ease anxiety or other mental health conditions – 6abc Philadelphia
# Summary Recent research indicates marijuana does not effectively treat anxiety or mental health conditions, and may increase psychosis risk in genetically predisposed individuals.
Read more →Will Spanberger allow marijuana marketplace to begin as planned or push the start date back?
Virginia Governor Abigail Spanberger is evaluating legislation regarding the timeline for initiating retail cannabis sales, with January 1st as a potential start date.
Read more →Clinical Commentary
# Clinical Reflection These news items signal three converging pressures on cannabis medicine practice: regulatory fragmentation (states tightening THC rules while federal scheduling remains unresolved), sobering evidence against cannabis for common mental health indications despite widespread patient use for anxiety and depression, and emerging opportunities in veterinary and metabolic disease applications that warrant clinical attention. As clinicians, we must reconcile patients’ growing reliance on cannabis for psychiatric symptoms with recent meta-analytic evidence showing no benefit for anxiety or mood disorders, while simultaneously navigating a patchwork of state regulations that increasingly distinguish between THC and THCA content. The field appears to be maturing toward more specific therapeutic targets (metabolic disease, cannabinoid receptor biology) rather than broad-spectrum mental health claims, requiring us to deprescribe thoughtfully and engage in shared decision-making grounded
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: